ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,965Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 103

$333K Total Retail Price of All Prescriptions

Rank: 54 out of 103

282 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 282 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 282 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,455 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 487 475 1 3
SIMVASTATIN 453 417 2 2
FUROSEMIDE 423 403 3 4
LISINOPRIL 367 343 4 5
LEVOTHYROXINE SODIUM 332 308 5 1
METOPROLOL TARTRATE 281 264 6 9
ATENOLOL 187 187 7 14
WARFARIN SODIUM 187 173 7 7
AMLODIPINE BESYLATE 185 185 9 6
SERTRALINE HCL 174 172 10 21
HYDROCHLOROTHIAZIDE 152 139 11 16
POTASSIUM CHLORIDE 146 146 12 10
METOPROLOL SUCCINATE 143 138 13 8
DONEPEZIL HCL 135 135 14 28
LANTUS 129 126 15 39
ALENDRONATE SODIUM 121 107 16 19
PREDNISONE 115 115 17 24
DIGOXIN 113 113 18 25
HYDROCODONE-ACETAMINOPHEN 112 106 S3 19 11
INSULIN SYRINGE 111 103 20 75
METFORMIN HCL 107 98 21 13
TRAMADOL HCL 100 90 22 17
GABAPENTIN 96 96 23 22
CRESTOR 95 95 24 27
RANITIDINE HCL 92 92 25 53
AZITHROMYCIN 90 83 26 44
METHYLPREDNISOLONE 88 80 27 86
CYCLOBENZAPRINE HCL 87 74 R 28 83
TERAZOSIN HCL 85 85 29 104
TAMSULOSIN HCL 84 80 30 23
ATORVASTATIN CALCIUM 82 75 31 18
ZOLPIDEM TARTRATE 80 75 32 29
NITROGLYCERIN PATCH 77 77 33 89
CLOPIDOGREL 75 75 34 32
LOSARTAN POTASSIUM 72 72 35 12
GLYBURIDE 70 70 R 36 76
FENTANYL 70 70 S2 36 34
ALLOPURINOL 65 65 38 26
CITALOPRAM HBR 61 59 39 15
OXYBUTYNIN CHLORIDE 58 58 40 144
CIPROFLOXACIN HCL 58 54 40 59
TRIAMTERENE-HCTZ 54 54 42 38
CEPHALEXIN 54 49 42 72
SPIRIVA 54 42 42 64
CARBIDOPA-LEVODOPA 51 51 45 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.